Cost-effective and disposable label-free voltammetric immunosensor for sensitive detection of interleukin-6.


Journal

Biosensors & bioelectronics
ISSN: 1873-4235
Titre abrégé: Biosens Bioelectron
Pays: England
ID NLM: 9001289

Informations de publication

Date de publication:
01 Oct 2022
Historique:
received: 18 01 2022
revised: 01 06 2022
accepted: 06 06 2022
pubmed: 28 6 2022
medline: 8 7 2022
entrez: 27 6 2022
Statut: ppublish

Résumé

IL-6 detection is highly desirable since can monitor many diseases in humans and assess the response to treatments. Herein, two novel label-free voltammetric immunosensors for rapid and accurate interleukin-6 (IL-6) detection in human serum are presented. The immunosensors are fabricated by immobilising two different IL-6 antibodies, identified as mAb-IL-6 clone-5 and clone-7, on in-house produced screen-printed electrodes modified with inexpensive recycling biochar (Bio-SPEs). To ensure high structural fidelity and performance, an in-depth electrochemical characterization of the layer-by-layer assembly of the immunosensor was conducted by cyclic voltammetry (CV) and sensing was performed using square wave voltammetry (SWV). The two immunosensors showed good analytical performances in human serum, exhibiting a wide linear range (LR) between 26-125 and 30-138 pg/mL, a good limit of detection (LOD) of 4.8 and 5.4 pg/mL and selectivity for IL-6 over other common cytokines, including IL-1β and TNF-α. Performance comparison of IL-6 immunosensors with those of a commercial spectrophotometric ELISA kit (LOD of 20 pg/mL, RSD% of 15%) denotes a better sensitivity and reproducibility of the proposed label-free devices, associated with a reduced detection time (30 min instead of more than 3 h for ELISA test). Furthermore, the proposed immunosensors were successfully applied in blood samples (with only a dilution of 1:100 v/v in PBS and without additional treatments) with good sensitivity (LOD of 14.3 pg/mL) and reproducibility (RSD% < 11%), thus paving the way for their application as viable diagnostic and therapeutic point-of-care tools alternative to the IL-6 detection techniques routinely used (ELISA and Western Blot).

Identifiants

pubmed: 35760020
pii: S0956-5663(22)00507-3
doi: 10.1016/j.bios.2022.114467
pii:
doi:

Substances chimiques

Interleukin-6 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

114467

Informations de copyright

Copyright © 2022 Elsevier B.V. All rights reserved.

Auteurs

Rocco Cancelliere (R)

Department of Chemical Sciences and Technologies, University of Rome Tor Vergata, Via della Ricerca Scientifica 1, 00133, Roma, Italy.

Alessio Di Tinno (A)

Department of Chemical Sciences and Technologies, University of Rome Tor Vergata, Via della Ricerca Scientifica 1, 00133, Roma, Italy; Department of Electrical and Information Engineering, University of Cassino and Southern Lazio, 03043, Cassino, FR, Italy.

Andrea Maria Di Lellis (AM)

S2G Technologies Srl Tecnopolo Tiburtino, Via Giacomo Peroni 444, 00131, Roma, Italy.

Giorgio Contini (G)

Istituto di Struttura della Materia-CNR (ISM-CNR), Via Fosso del Cavaliere 100, 00133, Roma, Italy; Department of Physics, University of Rome Tor Vergata, Via della Ricerca Scientifica 1, 00133, Roma, Italy. Electronic address: giorgio.contini@ism.cnr.it.

Laura Micheli (L)

Department of Chemical Sciences and Technologies, University of Rome Tor Vergata, Via della Ricerca Scientifica 1, 00133, Roma, Italy. Electronic address: laura.micheli@uniroma2.it.

Emanuela Signori (E)

Istituto di Farmacologia Traslazionale-CNR (IFT-CNR), Via Fosso del Cavaliere 100, 00133, Roma, Italy. Electronic address: emanuela.signori@ift.cnr.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH